163 related articles for article (PubMed ID: 31419525)
1. SOX17 in cellular reprogramming and cancer.
Tan DS; Holzner M; Weng M; Srivastava Y; Jauch R
Semin Cancer Biol; 2020 Dec; 67(Pt 1):65-73. PubMed ID: 31419525
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Srivastava Y; Tan DS; Malik V; Weng M; Javed A; Cojocaru V; Wu G; Veerapandian V; Cheung LWT; Jauch R
FEBS J; 2020 Jan; 287(1):122-144. PubMed ID: 31569299
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
[TBL] [Abstract][Full Text] [Related]
4. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network.
Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM
Elife; 2020 Sep; 9():. PubMed ID: 32894225
[TBL] [Abstract][Full Text] [Related]
5. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming.
Aksoy I; Jauch R; Eras V; Chng WB; Chen J; Divakar U; Ng CK; Kolatkar PR; Stanton LW
Stem Cells; 2013 Dec; 31(12):2632-46. PubMed ID: 23963638
[TBL] [Abstract][Full Text] [Related]
6. OCT4 Coordinates with WNT Signaling to Pre-pattern Chromatin at the SOX17 Locus during Human ES Cell Differentiation into Definitive Endoderm.
Ying L; Mills JA; French DL; Gadue P
Stem Cell Reports; 2015 Oct; 5(4):490-8. PubMed ID: 26411902
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17.
Hu H; Ho DHH; Tan DS; MacCarthy CM; Yu CH; Weng M; Schöler HR; Jauch R
Nucleic Acids Res; 2023 Sep; 51(17):8934-8956. PubMed ID: 37607832
[TBL] [Abstract][Full Text] [Related]
8. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
9. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
11. Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier.
Corada M; Orsenigo F; Bhat GP; Conze LL; Breviario F; Cunha SI; Claesson-Welsh L; Beznoussenko GV; Mironov AA; Bacigaluppi M; Martino G; Pitulescu ME; Adams RH; Magnusson P; Dejana E
Circ Res; 2019 Feb; 124(4):511-525. PubMed ID: 30591003
[TBL] [Abstract][Full Text] [Related]
12. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
13. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
14. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.
Yin D; Jia Y; Yu Y; Brock MV; Herman JG; Han C; Su X; Liu Y; Guo M
Discov Med; 2012 Jul; 14(74):33-40. PubMed ID: 22846201
[TBL] [Abstract][Full Text] [Related]
15. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
16. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm.
Aksoy I; Jauch R; Chen J; Dyla M; Divakar U; Bogu GK; Teo R; Leng Ng CK; Herath W; Lili S; Hutchins AP; Robson P; Kolatkar PR; Stanton LW
EMBO J; 2013 Apr; 32(7):938-53. PubMed ID: 23474895
[TBL] [Abstract][Full Text] [Related]
17. Sox17 facilitates the differentiation of mouse embryonic stem cells into primitive and definitive endoderm in vitro.
Qu XB; Pan J; Zhang C; Huang SY
Dev Growth Differ; 2008 Sep; 50(7):585-93. PubMed ID: 19238729
[TBL] [Abstract][Full Text] [Related]
18. SOX17 directly activates Zfp202 transcription during in vitro endoderm differentiation.
Patterson ES; Addis RC; Shamblott MJ; Gearhart JD
Physiol Genomics; 2008 Aug; 34(3):277-84. PubMed ID: 18523156
[TBL] [Abstract][Full Text] [Related]
19. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
